Enabling
mental health breakthroughs
Emerging therapies and clinical research in psychedelic medicine
Participants
Be the change
Participants in research trials help improve and create breakthroughs in mental health treatments. Join us in developing and refining leading-edge mental health therapies. Your participation has the potential to improve and even save lives.
Interested in enrolling in a study?
Explore current opportunities →Sponsors
Access to an inner world
We are experienced in hosting clinical trials and research studies for central nervous system conditions. Cedar Clinical Research offers important, telling data through access to a significant population of psychiatric patients.
Interested in clinical trial hosting services?
Learn more about hosting →Our capabilities
Cedar Clinical Research offers a range of clinical services and studies.
Phase I-IV
Clinical Trials
Bioequivalence
Bioavailability
Pharmacogenetic
Studies
Psychedelic
Studies
Cedar’s milestones in psychedelic research
From our pivotal ketamine clinical trial for Treatment-Resistant Major Depressive Disorder in 2012 to completing our first clinical trial of Emotion-Focused Ketamine-Assisted Psychotherapy (EF-KAP) in 2020, Cedar has developed a deep foundation of expertise across a broad spectrum of research.
Our partners and sponsors
Current studies
Treatment Resistant Depression — Adults
Depression is a common metal illness that affects quality of life. Many people who have depression still experience symptoms despite being on treatments.
Post-Traumatic Stress Disorder — Adults
Individuals with PTSD generally have difficulty recovering from a terrifying event, whether they witness or experience it, resulting in nightmares, unwanted memories, heightened reactions, anxiety, or depressed mood.
Negative Symptoms of Schizophrenia – Adults
With Negative Symptoms of Schizophrenia, people lose the desire to do anything, including a lack of drive and motivation and limited interactions with others.